Literature DB >> 1624259

The cost and availability of therapeutic options in advanced prostatic carcinoma in Turkey.

N Y Ilker1, O Dillioğlugil, A Akdaş.   

Abstract

Advanced prostatic carcinoma may be treated by a variety of methods of endocrine manipulation which affect the production of androgens. This can either be done by bilateral orchiectomy or by a number of drugs. Orchiectomy has two advantages: low cost and being a once-only procedure. This report outlines the costs of various methods of hormonal treatment and compares them with each other in Turkey.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624259     DOI: 10.1007/bf02549643

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  11 in total

1.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

Authors:  Charles Huggins; Clarence V Hodges
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

Review 2.  Hormonal management of stage D carcinoma of the prostate.

Authors:  J Trachtenberg
Journal:  Urol Clin North Am       Date:  1987-11       Impact factor: 2.241

Review 3.  Cancer of the prostate: epidemiology and aetiology.

Authors:  D G Zaridze; P Boyle
Journal:  Br J Urol       Date:  1987-06

Review 4.  Is there a best endocrine management of prostatic carcinoma?

Authors:  M R Robinson
Journal:  Prog Clin Biol Res       Date:  1988

5.  Prostatic carcinoma.

Authors:  D Kirk
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-23

Review 6.  Carcinoma of the prostate: a review.

Authors:  W J Catalona; W W Scott
Journal:  J Urol       Date:  1978-01       Impact factor: 7.450

7.  Hormonal therapy of prostatic cancer.

Authors:  W W Scott; M Menon; P C Walsh
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

8.  Bilateral orchiectomy for carcinoma of prostate. Response of serum testosterone and clinical response to subsequent estrogen therapy.

Authors:  R C Klugo; R N Farah; J C Cerny
Journal:  Urology       Date:  1981-01       Impact factor: 2.649

9.  Subcapsular orchiectomy with intracapsular testicular prosthesis for metastatic prostate carcinoma.

Authors:  K L Short; L W Howerton; H Holt; M Amin
Journal:  Urology       Date:  1984-07       Impact factor: 2.649

Review 10.  Treatment of advanced prostatic cancer.

Authors:  P C Sogani; W R Fair
Journal:  Urol Clin North Am       Date:  1987-05       Impact factor: 2.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.